#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA744111	F	Tested for in vitro cell growth inhibition of NCI-N417 cells	Homo sapiens	1	ALA1127034	cell-based format	Scientific Literature
2.	ALA744112	F	Tested for in vitro cell growth inhibition of NCI-N417 cells; No significant effect	Homo sapiens	1	ALA1127034	cell-based format	Scientific Literature
3.	ALA752387	F	Compound was evaluated for inhibitory activity against N 417 human lung cancer cell line	Homo sapiens	6	ALA1125566	cell-based format	Scientific Literature
4.	ALA752388	F	Cytotoxicity against N 417 human lung cancer cell line	Homo sapiens	8	ALA1125566	cell-based format	Scientific Literature
5.	ALA751474	F	In vitro tumor cell growth inhibitory activity against Human lung small-cell carcinoma cell NCI-H-417	Homo sapiens	2	ALA1129576	cell-based format	Scientific Literature
6.	ALA1243868	F	Anticancer activity against human NCI-N417 cells xenografted in athymic mouse assessed as tumor caspase-3 cleavage at 100 mg/kg, ip administered daily for 5 consecutive days measured after 12 hrs post last dose by immunohistochemistry	Homo sapiens	1	ALA1240328	organism-based format	Scientific Literature
7.	ALA1243869	F	Anticancer activity against human NCI-N417 cells xenografted in athymic mouse assessed as decrease in tumor Akt activity at 100 mg/kg, ip administered daily for 5 consecutive days measured after 12 hrs post last dose by immunohistochemistry	Homo sapiens	1	ALA1240328	organism-based format	Scientific Literature
8.	ALA1243870	F	Anticancer activity against human NCI-N417 cells xenografted in ip dosed athymic mouse assessed as tumor caspase-3 cleavage administered daily for 5 consecutive days measured after 12 hrs post last dose by immunohistochemistry	Homo sapiens	1	ALA1240328	organism-based format	Scientific Literature
9.	ALA1243871	F	Anticancer activity against human NCI-N417 cells xenografted in ip dosed athymic mouse assessed as decrease in tumor Akt activity administered daily for 5 consecutive days measured after 12 hrs post last dose by immunohistochemistry	Homo sapiens	1	ALA1240328	organism-based format	Scientific Literature
10.	ALA1243872	F	Anticancer activity against human NCI-N417 cells xenografted in athymic mouse assessed as decrease in tumor Akt activity at 75 mg/kg, ip administered daily for 5 consecutive days measured after 6 hrs post last dose by immunohistochemistry	Homo sapiens	1	ALA1240328	organism-based format	Scientific Literature
11.	ALA1243873	F	Anticancer activity against human NCI-N417 cells xenografted in athymic mouse assessed as decrease in tumor Akt activity at 75 mg/kg, ip administered daily for 5 consecutive days measured after 36 hrs post last dose by immunohistochemistry	Homo sapiens	1	ALA1240328	organism-based format	Scientific Literature
12.	ALA1243874	F	Anticancer activity against human NCI-N417 cells xenografted in athymic mouse assessed as tumor growth inhibition at nontoxic dose administered ip daily for 5 consecutive days measured on day 20 post tumor implantation	Homo sapiens	1	ALA1240328	organism-based format	Scientific Literature
13.	ALA2015364	F	Cytotoxicity against human NCI-N417 cells after 96 hrs by trypan blue exclusion assay	Homo sapiens	2	ALA2010670	cell-based format	Scientific Literature
14.	ALA2400506	F	Cytotoxicity against human NCI-N417 cells after 96 hrs by trypan blue exclusion assay	Homo sapiens	4	ALA2396655	cell-based format	Scientific Literature
15.	ALA3117385	F	Cytotoxicity against human NCI-N417 cells after 96 hrs by Cell-Titer Blue assay	Homo sapiens	1	ALA3112420	cell-based format	Scientific Literature
16.	ALA5261779	F	Cytotoxicity against human NCI-H417 cells measured after 8 days	Homo sapiens	2	ALA5260810	cell-based format	Scientific Literature